Developer docs
API playgroundTry for free, no card

Search company profiles

Iridia

Full company profile

uuid0000vub

Namestring
Iridia
Legal namestring
Iridia Inc.
Websiteurl
iridia.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Iridia is a privately held nanotechnology company founded in 2016 and headquartered in Carlsbad/San Diego, California. The company has developed a proprietary Molecular Avatar Technology platform that combines engineered synthetic DNA molecules with nanotechnology to embed invisible, tamper-proof molecular identities and customizable data directly into physical products, coatings, plastics, and liquids. The technology is claimed to operate without electronic components, require zero energy, and maintain integrity for thousands of years, distinguishing it from conventional RFID, NFC, and blockchain-only provenance approaches.

Iridia's product surface spans the core Molecular Avatar platform plus three specialized variants: the Molecular Wallet for cold storage of cryptographic private keys (Bitcoin, Ethereum, Solana) and archival data; Embedded Molecular Data Technology for integration with additive manufacturing; and a Product Verification Portal for enterprise authentication workflows. The Molecular Wallet was validated through the successful March 2025 landing of molecular-stored data on the lunar surface via Firefly Aerospace's Blue Ghost lander in Mare Crisium.

The company monetizes through licensing of its molecular technology, sale of Molecular Wallet hardware, and professional services for enterprise integration. Pricing is quote-based and not publicly disclosed. Go-to-market combines direct enterprise sales (targeting aerospace, defense, luxury retail, supply chain, infrastructure/electronics, sports/collectibles, and art verticals) with channel partnerships including SNL Creative (medical devices), Bond by Solana Labs and Baxus (spirits), and Arweave/ASI Alliance (decentralized data). Cumulative disclosed funding is approximately $40 million across rounds from 2017–2021, led by Prime Movers Lab and LifeSci Venture Partners with participation from Western Digital Capital, ATEM Capital, JSR, and others.

Short descriptiontext

Iridia is a Carlsbad-based nanotechnology company that embeds tamper-proof synthetic DNA molecular identities into physical products for authentication, traceability, and ultra-long-term data storage across luxury goods, medical devices, aerospace, and crypto-asset verticals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular authentication technology, DNA-based data storage, product anti-counterfeiting, supply chain traceability, molecular identity tagging
Industry2 codes
PRIMARYHDABAEAH
Data Protection & Archiving (WORM, Long-Term Retention)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Storage Infrastructure (SAN/NAS/Object/Backup)
SECONDARYFSAPALAA
Decentralized Storage Networks (IPFS/Filecoin/Arweave, archival & retrieval)
Financial & Insurance/Blockchain & Web3/Decentralized Storage, Compute & Networking (DePIN, IPFS, compute markets)
NAICS code3 codes
  • Research and Development in Nanotechnology541713
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Computer Storage Device Manufacturing334112
SIC code2 codes
  • Computer Storage Devices3572
  • Medicinal Chemicals & Botanical Products2833
Product category
Molecular Authentication & DNA-based Data Storage
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Molecular Technology Licensing and Solutions
TypeLicensing Royalties
Description

Iridia provides molecular technology solutions for product authenticity, integrity, and traceability across various industries through licensing their Molecular Avatar Technology platform.

news.iridia.com
2Molecular Data Storage Products
TypeHardware Sales
Description

Sale of molecular storage devices including the Molecular Wallet for cryptocurrency backup and archival data storage applications for enterprises, financial institutions, and high-net-worth individuals.

news.iridia.com
3Enterprise Implementation Services
TypeProfessional Services
Description

Professional services for integrating molecular technology into customer products and supply chains, including custom coating solutions and metadata infusion for medical devices and other applications.

news.iridia.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Iridia combines precisely engineered synthetic DNA molecules with nanotechnology to embed invisible, tamper-proof molecular identities and customizable information into products, materials, and data storage systems. The technology supports product authentication, supply chain traceability, archival data storage, and digital asset cold storage across multiple enterprise verticals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 8% of medical devices in circulation estimated to be counterfeit according to WHO - Iridia's technology addresses this critical safety issue
+1 more record
Product overview1 text field

Iridia offers a unified Molecular Avatar Technology platform that combines synthetic DNA molecules and nanotechnology to embed unalterable molecular identity into physical products. The core platform provides four main capabilities: Authenticity (verifiable one-of-a-kind offerings), Traceability (supply chain transparency from production to end-user), Data Infusion (embedding data directly into product materials), and Premium Experiences (personalized and Web3-enabled utilities for product owners). The platform serves multiple industries including Art, Luxury Retail, Supply Chain, Infrastructure & Electronics, Sports & Collectibles, and Aerospace & Defense. Specialized variants include the Molecular Wallet for secure digital asset cold storage, Embedded Molecular Data Technology for manufacturing integration, and a Product Verification Platform portal for authentication services.

Product and service1 record
1Molecular Avatar Technology
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-15
Description

Partnership to store Arweave Genesis Block data on the moon using Iridia's molecular technology. Arweave is an open-source protocol for permanent data storage, and this collaboration establishes an off-world archive demonstrating extreme data preservation capabilities.

2ASI Alliance (SingularityNET, Fetch.ai, Ocean Protocol)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-15
Description

Partnership with the Artificial Superintelligence Alliance to store ASI (FET) tokens on the lunar surface using Iridia's Molecular Wallet technology. Represents a significant step toward decentralized AI systems with data stored beyond Earth.

news.iridia.com
3LifeShip
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-15
Description

LifeShip provided the lunar payload aboard Dragonfly Aerospace's Blue Ghost Lander to carry Iridia's molecular data payloads to the moon's surface as part of humanity's first off-world data archive.

news.iridia.com
4Bond by Solana Labs
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2024-12-11
Description

Bond by Solana Labs partnered with Iridia to introduce onchain molecular authentication for spirits. Bond's web3 loyalty platform combines blockchain-based authentication with Iridia's molecular signatures for dual-layered spirits verification.

news.iridia.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-12-11
Description

Baxus, a global marketplace for collectible spirits, partnered with Iridia and Bond by Solana Labs to offer molecular-authenticated whiskey bottles. First implementation was Oakley Spirits 20-year Kentucky bourbon.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-24
Description

Strategic partnership combining Iridia's molecular data embedding technology with SNL Creative's precision 3D printing capabilities for medical device manufacturing. Focuses on cryptographic security coatings, metadata infusion, and embedded traceability for enhanced patient safety and regulatory compliance.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Applied DNA Sciences uses synthetic DNA-based taggants and molecular markers for product authentication, brand protection, and supply chain traceability across textiles, cosmetics, and pharmaceuticals. It is the closest direct peer to Iridia's Molecular Avatar Technology, serving overlapping customer pain points around counterfeiting and provenance with the same underlying DNA-marker chemistry.

TypeDirect peer
Description

TruTag develops covert, edible silica-based nano-tag authentication solutions for pharmaceuticals, food, and industrial parts. It targets the same product authentication and anti-counterfeiting use cases as Iridia across overlapping verticals (pharma, electronics, luxury), differing primarily in tag chemistry (silica vs. synthetic DNA).

TypeDirect peer
Description

Haelixa embeds synthetic DNA markers into textile fibers and raw materials to enable traceability and authenticity verification in fashion, luxury, and industrial supply chains. It is a direct competitor in DNA-based traceability with overlapping customer profile in luxury and apparel verticals.

TypeEmerging player
Description

Catalog is building a DNA-based digital data storage platform encoding large-scale information into synthetic DNA. It overlaps with Iridia's Molecular Wallet and archival storage positioning, though Catalog focuses on exabyte-scale data archival rather than authentication or crypto custody.

TypeBroad incumbent
Description

Twist Bioscience is a public DNA synthesis platform serving synthetic biology, genomics, and DNA data storage applications. It is both a potential infrastructure supplier to Iridia and a competitor in the DNA data storage opportunity, with broader scale but less specialization in authentication.

TypeOthers
Description

Systech provides serialization, track-and-trace, and authentication solutions for pharmaceuticals and consumer goods. It addresses the same product authentication and anti-counterfeiting problems as Iridia, but with established software/serialization stack rather than molecular markers, and serves overlapping pharma and consumer goods customers.

TypeBroad incumbent
Description

Avery Dennison is a global leader in RFID tags, NFC labels, and brand-protection solutions for retail, apparel, and supply chain. It competes with Iridia in authentication and traceability across luxury, retail, and supply chain verticals, representing the cheaper incumbent alternative at scale.

8DNA Script
TypeOthers
Description

DNA Script is an enzymatic DNA synthesis platform enabling faster, on-demand oligonucleotide production. It is a potential upstream supplier whose technology could materially reduce Iridia's per-unit synthesis costs, making it a strategically important ecosystem partner rather than direct competitor.

TypeBroad incumbent
Description

AlpVision provides digital fingerprint and covert marking authentication for pharmaceuticals, luxury goods, and consumer products. It overlaps with Iridia in authentication use cases but relies on software/digital techniques rather than physical molecular markers, positioning it as a competing incumbent.

TypeBroad incumbent
Description

Colorcon supplies film coatings, specialty excipients, and anti-counterfeiting solutions for pharmaceutical and consumer goods packaging. It overlaps with Iridia in pharmaceutical authentication and traceability via coating-integrated security features, serving as a broader incumbent in adjacent formulation/coating chemistry.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Iridia

Molecular Authentication & DNA-based Data Storageiridia.com

Iridia is a Carlsbad-based nanotechnology company that embeds tamper-proof synthetic DNA molecular identities into physical products for authentication, traceability, and ultra-long-term data storage across luxury goods, medical devices, aerospace, and crypto-asset verticals.

What Iridia does

Iridia is a privately held nanotechnology company founded in 2016 and headquartered in Carlsbad/San Diego, California. The company has developed a proprietary Molecular Avatar Technology platform that combines engineered synthetic DNA molecules with nanotechnology to embed invisible, tamper-proof molecular identities and customizable data directly into physical products, coatings, plastics, and liquids. The technology is claimed to operate without electronic components, require zero energy, and maintain integrity for thousands of years, distinguishing it from conventional RFID, NFC, and blockchain-only provenance approaches.

Iridia's product surface spans the core Molecular Avatar platform plus three specialized variants: the Molecular Wallet for cold storage of cryptographic private keys (Bitcoin, Ethereum, Solana) and archival data; Embedded Molecular Data Technology for integration with additive manufacturing; and a Product Verification Portal for enterprise authentication workflows. The Molecular Wallet was validated through the successful March 2025 landing of molecular-stored data on the lunar surface via Firefly Aerospace's Blue Ghost lander in Mare Crisium.

The company monetizes through licensing of its molecular technology, sale of Molecular Wallet hardware, and professional services for enterprise integration. Pricing is quote-based and not publicly disclosed. Go-to-market combines direct enterprise sales (targeting aerospace, defense, luxury retail, supply chain, infrastructure/electronics, sports/collectibles, and art verticals) with channel partnerships including SNL Creative (medical devices), Bond by Solana Labs and Baxus (spirits), and Arweave/ASI Alliance (decentralized data). Cumulative disclosed funding is approximately $40 million across rounds from 2017–2021, led by Prime Movers Lab and LifeSci Venture Partners with participation from Western Digital Capital, ATEM Capital, JSR, and others.

Iridia firmographics

Firmographics
Name
Iridia
Legal name
Iridia Inc.
Website
https://iridia.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Iridia is a Carlsbad-based nanotechnology company that embeds tamper-proof synthetic DNA molecular identities into physical products for authentication, traceability, and ultra-long-term data storage across luxury goods, medical devices, aerospace, and crypto-asset verticals.
Ownership category
akta.pro rank

Iridia industry classification

Industry
Product category
Molecular Authentication & DNA-based Data Storage
NAICS
Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Storage Device Manufacturing (334112)
SIC
Computer Storage Devices (3572), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHDABAEAH
Data Protection & Archiving (WORM, Long-Term Retention)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Storage Infrastructure (SAN/NAS/Object/Backup)
SECONDARYFSAPALAA
Decentralized Storage Networks (IPFS/Filecoin/Arweave, archival & retrieval)
Financial & Insurance/Blockchain & Web3/Decentralized Storage, Compute & Networking (DePIN, IPFS, compute markets)

Keywords

  • Molecular authentication technology
  • DNA-based data storage
  • Product anti-counterfeiting
  • Supply chain traceability
  • Molecular identity tagging

Where Iridia is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Iridia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Molecular Technology Licensing and Solutions: Iridia provides molecular technology solutions for product authenticity, integrity, and traceability across various industries through licensing their Molecular Avatar Technology platform.
  2. Molecular Data Storage Products: Sale of molecular storage devices including the Molecular Wallet for cryptocurrency backup and archival data storage applications for enterprises, financial institutions, and high-net-worth individuals.
  3. Enterprise Implementation Services: Professional services for integrating molecular technology into customer products and supply chains, including custom coating solutions and metadata infusion for medical devices and other applications.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Iridia product offering

Product offering

Core offering

Iridia combines precisely engineered synthetic DNA molecules with nanotechnology to embed invisible, tamper-proof molecular identities and customizable information into products, materials, and data storage systems. The technology supports product authentication, supply chain traceability, archival data storage, and digital asset cold storage across multiple enterprise verticals.

Product overview

Iridia offers a unified Molecular Avatar Technology platform that combines synthetic DNA molecules and nanotechnology to embed unalterable molecular identity into physical products. The core platform provides four main capabilities: Authenticity (verifiable one-of-a-kind offerings), Traceability (supply chain transparency from production to end-user), Data Infusion (embedding data directly into product materials), and Premium Experiences (personalized and Web3-enabled utilities for product owners). The platform serves multiple industries including Art, Luxury Retail, Supply Chain, Infrastructure & Electronics, Sports & Collectibles, and Aerospace & Defense. Specialized variants include the Molecular Wallet for secure digital asset cold storage, Embedded Molecular Data Technology for manufacturing integration, and a Product Verification Platform portal for authentication services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Avatar Technology

Quantifiable outcome

  • 8% of medical devices in circulation estimated to be counterfeit according to WHO - Iridia's technology addresses this critical safety issue
  • +1 more outcomes

Companies that use Iridia

Customer profile

Named customers2 records

Segments9 records

Ideal customer profiles5 records

Iridia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Iridia partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • ArweavecoreStrategic or Co-development Partner · 15 January 2025Partnership to store Arweave Genesis Block data on the moon using Iridia's molecular technology. Arweave is an open-source protocol for permanent data storage, and this collaboration establishes an off-world archive demonstrating extreme data preservation capabilities.
  • ASI Alliance (SingularityNET, Fetch.ai, Ocean Protocol)coreStrategic or Co-development Partner · 15 January 2025Partnership with the Artificial Superintelligence Alliance to store ASI (FET) tokens on the lunar surface using Iridia's Molecular Wallet technology. Represents a significant step toward decentralized AI systems with data stored beyond Earth.
  • LifeShipcoreStrategic or Co-development Partner · 15 January 2025LifeShip provided the lunar payload aboard Dragonfly Aerospace's Blue Ghost Lander to carry Iridia's molecular data payloads to the moon's surface as part of humanity's first off-world data archive.
  • Bond by Solana LabscoreGTM or Marketing Partner · 11 December 2024Bond by Solana Labs partnered with Iridia to introduce onchain molecular authentication for spirits. Bond's web3 loyalty platform combines blockchain-based authentication with Iridia's molecular signatures for dual-layered spirits verification.
  • BaxuscoreChannel Partner/ Reseller/ Distributor · 11 December 2024Baxus, a global marketplace for collectible spirits, partnered with Iridia and Bond by Solana Labs to offer molecular-authenticated whiskey bottles. First implementation was Oakley Spirits 20-year Kentucky bourbon.
  • SNL CreativecoreStrategic or Co-development Partner · 24 June 2024Strategic partnership combining Iridia's molecular data embedding technology with SNL Creative's precision 3D printing capabilities for medical device manufacturing. Focuses on cryptographic security coatings, metadata infusion, and embedded traceability for enhanced patient safety and regulatory compliance.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Iridia competitors and assessment

Company assessment

Direct peers

  • Applied DNA Sciences: Applied DNA Sciences uses synthetic DNA-based taggants and molecular markers for product authentication, brand protection, and supply chain traceability across textiles, cosmetics, and pharmaceuticals. It is the closest direct peer to Iridia's Molecular Avatar Technology, serving overlapping customer pain points around counterfeiting and provenance with the same underlying DNA-marker chemistry.
  • TruTag Technologies: TruTag develops covert, edible silica-based nano-tag authentication solutions for pharmaceuticals, food, and industrial parts. It targets the same product authentication and anti-counterfeiting use cases as Iridia across overlapping verticals (pharma, electronics, luxury), differing primarily in tag chemistry (silica vs. synthetic DNA).
  • Haelixa: Haelixa embeds synthetic DNA markers into textile fibers and raw materials to enable traceability and authenticity verification in fashion, luxury, and industrial supply chains. It is a direct competitor in DNA-based traceability with overlapping customer profile in luxury and apparel verticals.

Emerging players

  • Catalog Technologies: Catalog is building a DNA-based digital data storage platform encoding large-scale information into synthetic DNA. It overlaps with Iridia's Molecular Wallet and archival storage positioning, though Catalog focuses on exabyte-scale data archival rather than authentication or crypto custody.

Broad incumbents

  • Twist Bioscience: Twist Bioscience is a public DNA synthesis platform serving synthetic biology, genomics, and DNA data storage applications. It is both a potential infrastructure supplier to Iridia and a competitor in the DNA data storage opportunity, with broader scale but less specialization in authentication.
  • Avery Dennison: Avery Dennison is a global leader in RFID tags, NFC labels, and brand-protection solutions for retail, apparel, and supply chain. It competes with Iridia in authentication and traceability across luxury, retail, and supply chain verticals, representing the cheaper incumbent alternative at scale.
  • AlpVision: AlpVision provides digital fingerprint and covert marking authentication for pharmaceuticals, luxury goods, and consumer products. It overlaps with Iridia in authentication use cases but relies on software/digital techniques rather than physical molecular markers, positioning it as a competing incumbent.
  • Colorcon: Colorcon supplies film coatings, specialty excipients, and anti-counterfeiting solutions for pharmaceutical and consumer goods packaging. It overlaps with Iridia in pharmaceutical authentication and traceability via coating-integrated security features, serving as a broader incumbent in adjacent formulation/coating chemistry.

Others

  • Systech (privately held brand-protection unit): Systech provides serialization, track-and-trace, and authentication solutions for pharmaceuticals and consumer goods. It addresses the same product authentication and anti-counterfeiting problems as Iridia, but with established software/serialization stack rather than molecular markers, and serves overlapping pharma and consumer goods customers.
  • DNA Script: DNA Script is an enzymatic DNA synthesis platform enabling faster, on-demand oligonucleotide production. It is a potential upstream supplier whose technology could materially reduce Iridia's per-unit synthesis costs, making it a strategically important ecosystem partner rather than direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Iridia social profiles

Digital presence

Iridia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Iridia leadership team

Management profile

Number of profiles

Profiles9 records

Iridia funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Iridia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iridia

What does Iridia do?

Iridia combines precisely engineered synthetic DNA molecules with nanotechnology to embed invisible, tamper-proof molecular identities and customizable information into products, materials, and data storage systems. The technology supports product authentication, supply chain traceability, archival data storage, and digital asset cold storage across multiple enterprise verticals.

Is Iridia a public or private company?

Iridia is a private company. It is classified as venture growth investor backed and is currently operating.

When was Iridia founded?

Iridia was founded in 2016. It employs 11 to 50 people.

Where is Iridia based?

Iridia is headquartered in Carlsbad, United States, in the North America region.

How does Iridia make money?

Three revenue lines are on record. Molecular Technology Licensing and Solutions are the primary driver. The others are molecular Data Storage Products and enterprise Implementation Services.

Who are Iridia's main competitors?

Direct peers on record are Applied DNA Sciences, TruTag Technologies and Haelixa. Catalog Technologies is listed as an emerging player. Broad incumbents are Twist Bioscience, Avery Dennison, AlpVision and Colorcon. Others are Systech (privately held brand-protection unit) and DNA Script.

Does Iridia have an API?

No public API is recorded for Iridia.

What industry is Iridia in?

Iridia's product category is Molecular Authentication & DNA-based Data Storage. Its primary akta.pro industry code is HDABAEAH, Data Protection & Archiving (WORM, Long-Term Retention), with a secondary code of FSAPALAA, Decentralized Storage Networks (IPFS/Filecoin/Arweave, archival & retrieval). Its NAICS code is 541713 and its SIC code is 3572.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Built InTop San Diego, CA Semiconductor Startups 2025The article presents a curated list of semiconductor-related startups and companies operating in the San Diego, California area for 2025. It highlights firms such as Iridia, Inc., LeapFrog Semiconductor, and PXiSE Energy Solutions, detailing their specific technological focuses including DNA-based data storage, 5G components, and grid control systems. The content serves as an industry directory rather than reporting on a singular corporate event or transaction.openPR.comDNA Data Storage Market Growth 2025: Trends, Consumer Demand, and Key Opportunities | Illumina, Inc., Microsoft, Iridia, Inc., Twist BioscienceThe DNA data storage market is projected to grow from USD 33.5 million in 2024 to USD 184.10 million by 2031, a CAGR of 27.8%. Key players include Illumina, Microsoft, Iridia, and Twist Bioscience, with growth driven by healthcare demand and technological advances.GlobeNewswireIridia Embarks on Historic Mission to Send Bitcoin, Solana, and Ethereum to the Moon, Showcasing New Archival Molecular Data Storage TechnologyIridia launched a mission to send Bitcoin, Solana, Ethereum, and Arweave Genesis Block data to the moon's surface using its Molecular Wallet technology. The synthetic DNA-based storage is designed for millennia-scale durability and zero electromagnetic interference. The mission aims to demonstrate the technology's resilience in extreme conditions.GlobeNewswireIridia Partners with Arweave, ASI Alliance and LifeShip to Launch Humanity's First Molecular Data Archive and Digital Asset Infrastructure to the MoonIridia, Arweave, the ASI Alliance, and LifeShip announced a mission to store the Arweave Genesis Block and ASI tokens on the Moon via the Dragonfly Aerospace Lander. The data, encoded in synthetic DNA, is projected to last millennia. The mission also carries Bitcoin, Solana, and Ethereum from Iridia.GlobeNewswireBond by Solana Labs Partners with Baxus and Iridia to Debut Onchain Molecular Authentication TechBond by Solana Labs partnered with Baxus and Iridia to introduce onchain molecular authentication for spirits, embedding irreplicable digital molecular signatures into bottles. The first bottling, a 20-year-old Kentucky bourbon by Oakley Spirits, debuted at a New York event and will be sold on Baxus on December 17, 2024.GlobeNewswireIridia Raises $6 Million in Follow-on Equity Funding for Development of Industry’s First DNA-based Memory ChipsIridia, Inc. announced the closing of a $6 million follow-on equity funding round led by Prime Movers Lab to accelerate the development of DNA-based data storage prototypes. This investment follows a previous $24 million financing and will enable the company to double its headcount and physical footprint while validating its technology. The funding supports Iridia's goal of creating commercially viable, high-density data storage solutions that reduce the environmental impact of commercial data centers.SecSEC FORM DIridia, Inc. filed a Form D with the SEC for an exempt securities offering under Rule 504(b)(1) on November 12, 2021. The company reported a total offering amount of $5,999,999 USD with equity securities and two investors already participating. The filing was signed by CEO Murali Prahalad on November 15, 2021.